Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 26;14(1):19778.
doi: 10.1038/s41598-024-70708-9.

Deciphering simplified regional anticoagulation with citrate in intermittent hemodialysis: a clinical and computational study

Affiliations

Deciphering simplified regional anticoagulation with citrate in intermittent hemodialysis: a clinical and computational study

Julien Aniort et al. Sci Rep. .

Abstract

Regional citrate anticoagulation use in intermittent hemodialysis is limited by the increased risk of metabolic complications due to faster solute exchanges than with continuous renal replacement therapies. Several simplifications have been proposed. The objective of this study was to validate a mathematical model of hemodialysis anticoagulated with citrate that was then used to evaluate different prescription scenarios on anticoagulant effectiveness (free calcium concentration in dialysis filter) and calcium balance. A study was conducted in hemodialyzed patients with a citrate infusion into the arterial line and a 1.25 mmol/L calcium dialysate. Calcium and citrate concentrations were measured upstream and downstream of the citrate infusion site and in the venous line. The values measured in the venous lines were compared with those predicted by the model using Bland and Altman diagrams. The model was then used with 22 patients to make simulations. The model can predict the concentration of free calcium, bound to citrate or albumin, accurately. Irrespective of the prescription scenario a decrease in free calcium below 0.4 mmol/L was obtained only in a fraction of the dialysis filter. A zero or slightly negative calcium balance was observed, and should be taken into account in case of prolonged use.

Keywords: Anticoagulation; Calcium; Citrate; Dialysate; Hemodialysis; Modeling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
(A) Free calcium measured in blood at H1 on the arterial line upstream of the citrate injection site (patient), on the arterial line downstream of the citrate injection site (prefilter) and on the venous line (postfilter). P-value of ANOVA for repeated measures. Values with different letters are significantly different with post-hoc Bonferroni test. (B). Patient free calcium measured at H0, H1 and H4. P-value of ANOVA for repeated measures. (C). Serum citrate concentration pre- and postfilter. P-value of paired T test. (D). Free calcium vs citrate concentration. Black line represents polynomial regression.
Fig. 2
Fig. 2
Bland Altman diagram of postfilter values calculated with modeling, and measured values.
Fig. 3
Fig. 3
Simulations of hemodialysis with blood citrate infusion and a dialysate containing calcium (1.25 mmol/L). Percentage of membrane length with free calcium concentration < 0.4 mmol/L (A). Postfilter free calcium (B) and total calcium concentration (C) values. Calcium balance (D). Values are calculated for different dialysate and blood flows (prefilter citrate concentration 5 mmol/L) or different prefilter citrate concentrations (dialysate and blood flows set at 500 and 300 mL/min, respectively).

References

    1. European Best Practice Guidelines Expert Group on Hemodialysis. E.R.A. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system. Nephrol. Dial Transpl.17(Suppl7), 63–71 (2002). - PubMed
    1. Palevsky, P. M. et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis.61, 649–672 (2013). 10.1053/j.ajkd.2013.02.349 - DOI - PubMed
    1. Islam, M. S. et al. Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: A multicenter, randomized. Crossover Trial. Am. J. Kidney Dis.68, 752–762 (2016). 10.1053/j.ajkd.2016.05.013 - DOI - PubMed
    1. Laville, M. et al. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. Kidney Int.86, 1260–1267 (2014). 10.1038/ki.2014.225 - DOI - PubMed
    1. Meijers, B. et al. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: Results of the CiTED study. Nephrol. Dial Transpl.32, 707–714 (2017). 10.1093/ndt/gfw461 - DOI - PubMed

LinkOut - more resources